Global cell isolation market size is expected to reach $12.6 billion by 2023, according to P&S Intelligence.
The market is mainly driven by rising demand for biopharmaceuticals, increasing government funding for cell-based research, and growing research on personalized medicine.
Insights on market segments
Based on product, the cell isolation market is categorized into consumables and instruments. Consumables generated revenue of more than $2.5 billion, accounting for 61.4% share, in the market in 2017, owing to the increased demand for consumables, such as reagents, kits, media, and sera, for cell isolation techniques.
The cell isolation market is also categorized into human cells and animal cells. During the forecast period, the market is expected to witness higher growth in human cell isolation, with a CAGR of 19.9%. Advancements in stem cell technologies for the treatment of various diseases are expected to drive the cell isolation market growth for this category.
Based on technique, the market is categorized into centrifugation, surface marker, and filtration. Centrifugation technique is expected to continue generating the largest revenue in the cell isolation market in the coming years. The technique contributed 42.2% share to the market in 2017. This can be mainly attributed to the lower cost of the centrifugation technique as compared to other techniques.
Browse report overview with detailed TOC on "Cell Isolation Market by Product (Consumables, Instruments), by Cell Type (Human Cells, Animal Cells), by Technique (Centrifugation, Surface Marker, Filtration), by Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics, Therapeutics), by End User (Research Laboratories & Institutes, Hospitals & Diagnostic Laboratories, Cell Banks, Biotechnology & Biopharmaceutical Companies), by Geography (U.S., Canada, Germany, U.K, Japan, China, India, Brazil, Mexico, South Africa) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023" at:https://www.psmarketresearch.com/market-analysis/cell-isolation-market
Market is projected to witness the fastest growth in Asia-Pacific (APAC)
During the forecast period, the cell isolation market is projected to witness the fastest growth in APAC, with a CAGR of 22.1%. This is due to the increasing focus on basic and applied research by countries in the region. Besides, countries such as India and China have established research institutes promoting cell-based research. Hence, advanced healthcare infrastructure, rising adoption of innovative cell isolation products, and high demand for regenerative medicines are expected to drive the market growth in APAC in the coming years.
For instance, the 2012 launch of Abenomics, an economic revival plan by Japanese Prime Minister Shinzō Abe to accelerate the development and approval of regenerative medicines, is expected to boost the cell isolation market growth in Japan. In addition, increasing collaborations for the research and development of innovative therapies are expected to propel the demand for cell isolation products in the country.
Key players are entering into partnerships to increase their market share
In order to increase their market share, key players of the cell isolation industry are developing cost-effective and at-home therapy products. For instance, in August 2016, GE Healthcare entered into an agreement with STEMCELL Technologies Inc. to provide T-Cell reagents for commercial-scale cell therapy production. GE Healthcare agreed to commercialize cGMP-grade versions of STEMCELL Technologies’ T-Cell reagents for the isolation, activation, and culture of T-cells in clinical applications.
In June 2016, Thermo Fisher Scientific Inc. entered into a strategic partnership agreement with Cytonome/ST to be the exclusive distributor of a new line of flow cytometry cell-sorting technology that companies would co-develop. The key objective of the partnership was development of innovative and easy-to-use benchtop cell-sorting platforms.
Some of the other key players operating in the cell isolation industry are Terumo Corporation, General Electric Company, pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Danaher Corporation, Merck KGaA, Miltenyi Biotec GmbH, and Becton, Dickinson and Company.
GLOBAL CELL ISOLATION MARKET SEGMENTATION
Market Segmentation by Product
Market Segmentation by Cell Type
Market Segmentation by Technique
Market Segmentation by Application
Market Segmentation by End User
Market Segmentation by Geography